
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company's Digital Pathology Business Company to expand robust Enterprise Imaging offering with addition of Inspirata's Digital Pathology technology and team
News Release
December 20, 2022
Print
This news release is issued by FUJIFILM Corporation in Japan.
Fujifilm makes no representation that products on this news release are commercially available in all countries and regions including the US and EU.
Approved uses of healthcare products vary by country and region.
Specifications and appearance of products are subject to change without notice.
TOKYO, December 20, 2022 - FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced the company has entered into an asset purchase agreement to acquire the global digital pathology business of Tampa, Florida-based Inspirata, Inc. Upon completion of this agreement, Inspiratas Dynamyx digital pathology technology, employees and customers will become part of Fujifilm. The addition of digital pathology will expand Fujifilm's robust Synapse Enterprise Imaging offering to enable the integration of pathology images and data into a healthcare organization's electronic health record system and help to streamline care delivery for oncology patients and provider teams.
Building off the success of its established partnership with Inspirata, this acquisition marks Fujifilm's full-scale, global entry into the largely unpenetrated digital pathology market, where 85% of U.S., 86% of European, and 90% of Asian healthcare organizations are still running on analog.
Acquiring Inspirata's digital pathology business allows Fujifilm to be an even stronger healthcare partner - bridging a technological gap between pathology, radiology and oncology to facilitate a more collaborative approach to care delivery across the enterprise, says Teiichi Goto, president and CEO, representative director, FUJIFILM Corporation. We're thrilled to welcome Inspirata's digital pathology experts to Fujifilm's growing medical informatics business, along with their renowned global customer base, as together we work to drive the digitization and advancement of healthcare.
Dynamyx is an open, vendor-agnostic, end-to-end digital pathology solution. Dynamyx's software capabilities include using whole slide images from multiple scanning vendors to create an easier path for more pathology labs to digitize and realize the benefits of faster patient results, centralized imaging records, and enterprise access to images for all clinicians. It is installed in medical facilities that handle large volumes of pathological images across multiple lab locations, allowing the use of their preferred mix of laboratory and diagnostic technologies with confidence of full compatibility. According to a recent DeciBio article, Dynamyx is shown to have one of the largest partnership networks in the digital pathology space.
It will become part of Fujifilm's Synapse Enterprise Imaging portfolio - an award-winning suite of healthcare IT solutions that unify imaging, data access and workflows across the health system. With the addition of digital pathology, Fujifilm will offer one of the most comprehensive enterprise imaging portfolios on the market consisting of a Best in KLAS winning VNA, Radiology PACS, and Cardiology PACS, as well as an enterprise information system, cloud services, and 3D advanced visualization. Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development.
A $320 million global industry in 2021 projected to reach $640 million*1 by 2025, the rising number of cancer cases and the demonstrated benefits of digital pathology are fueling significant demand and market growth in the hospital and pharmaceutical industries, says Henry Izawa, president and CEO, FUJIFILM Healthcare Americas Corporation. These evolving clinical needs fuel Fujifilm's investment and innovation in the digital revolution, and we look forward to introducing Dynamyx and its host of unique features and benefits to our Synapse customers and prospects as we strive to enable more efficient medical diagnosis and high-quality care.
Since launching our European partnership with Inspirata three years ago, we've seen great success implementing our combined technologies in several healthcare organizations, notably in the UK, says Masa Fukumoto, managing director, FUJIFILM Healthcare Europe and senior vice president FUJIFILM Medical Systems Europe. Weve received feedback from customers anticipating digitizing pathology will be the most transformative thing they do for their practice, and we look forward to continuing our global expansion.
Digital pathology is the digitization of pathology slides to conduct software visualization analysis of a specimen rather than using microscopic slides. With a specialty as image and data heavy as pathology, digitization is key. Pathologists, clinicians, patients, researchers and biopharma companies alike may see benefits such as improved and more efficient workflows, enhanced collaboration, remote and centralized interpretation, faster patient results, overall cost savings, ROI, and increased precision of diagnosis. Fujifilm's existing partnership with Inspirata has demonstrated success in implementing these benefits for several global healthcare organizations.
Dynamyx has been cleared and/or approved for use in the U.S., Canada, Europe and the UK by each region's regulatory agency. Dynamyx technology ownership and ongoing development and engineering will be led in the U.S. by FUJIFILM Healthcare Americas Corporation and licensed to other regions. Timing for the completion of
More from Fujifilm
21/03/2023
Fujifilm will exhibit its extensive portfolio of analogue and digital packaging ...
21/03/2023
The recently announced partnership represents a shared commitment to innovation between Fujifilm and Josero, a Soyang Europe business Josero, a hardware suppl...
07/03/2023
Fujifilm has today confirmed that the Acuity Prime L flatbed printer is now commercially available. The printer, which was unveiled at FESPA 2022, is a larger v...
02/03/2023
RATINGEN, Germany, March 2, 2023 - FUJIFILM Europe GmbH, Imaging Division, has launched the new INSTAX MINI 12 Instant Camera (hereinafter MINI 12 ). Built wit...
02/03/2023
FUJIFILM Europe GmbH, Imaging Division, has announced the launch of Fujifilm's free, downloadable INSTAX UP! Smartphone App (hereinafter INSTAX UP!), design...
28/02/2023
Fujifilm today announces the launch of a new range of Luxel thermal platesetters...
13/02/2023
Fujifilm announces first global beta site for its Acuity Ultra Hybrid LED
February 13, 2023
Print
Echo House in Surbiton, UK will trial the new superwide ...
09/02/2023
A journey into food culture with the new issue of Fujifilms Women4Women magazine Eating nourishes the body, but cooking nourishes the soul' Fatma Top u A...
09/02/2023
Fujifilm announces the commercial availability of its ApeosPro C series of light...
08/02/2023
FUJIFILM Holdings to donate 50 million yen [approx. 355,000] for people affecte...
08/02/2023
Stepping up on sustainability
February 8, 2023
Print
The FUJIFILM Speciality Ink Systems award-winning factory in Broadstairs, UK, manufactures high perfo...
06/02/2023
Fujifilm Expands its RxD Inkjet Pigment Dispersions Colour Range
February 6, 2023
Print
New Orange, Green and Violet colours enable the formulation of ink...
23/01/2023
Fujifilm UK looks to boost wide format market presence with the appointment of n...
19/01/2023
Fujifilm Europe supports World Cancer Day
January 19, 2023
Print
Fujifilm Europe has announced its partnership with World Cancer Day, an initiative led by...
10/01/2023
Fujifilm continues to expand packaging team with new recruits in Italy and Spain New appointments will help to boost Fujifilm's packaging product sales ac...
06/01/2023
FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the...
06/01/2023
Thousands of photos from across Europe capture precious and special memories for...
05/01/2023
Fujifilm Announces Addition of Splatoon 3 and Other Unique Features in the Upda...
26/12/2022
Fujifilm and Utilization of Carbon Dioxide Institute sign a joint research agree...
21/12/2022
Fujifilm to open FUJIFILM Creative Village in Tokyo The new base for Fujifilm Group's design and IT development Designers and IT engineers exerting their ...
19/12/2022
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the ...
16/12/2022
Sustainable solutions at the heart of Fujifilm House' In October 2022, Fujifilm officially opened Fujifilm House', its new UK headquarters in Bedfor...
08/12/2022
Fujifilm announces new print mode and greater flexibility for Jet Press 750S Hig...
06/12/2022
Aztec Label invest in Fujifilm's Activ LED UV curing system to achieve lower...
24/11/2022
Fujifilm announces a change to its offset plate manufacturing in EMEA
November 24, 2022
Print
Fujifilm today announces the closure of the company's of...
22/11/2022
Red Sky Foundation and Fujifilm join forces to help little hearts and their fami...
07/11/2022
IPE Industria Gr fica invests in the future with Activ LED curing system from Fu...
02/11/2022
Introducing the FUJIFILM X-T5 Offering a compact and lightweight body, a host of new features and superior image quality:
November 2, 2022
Print
Fujifilm...
02/11/2022
Introducing the FUJINON XF30mmF2.8 R LM WR Macro Offering macro photography at a 1:1 magnification ratio
Latest lens to join the range boasts a compact, lig...
02/11/2022
Fujifilm to showcase the full capabilities of its wide format range at event hos...
01/11/2022
Fujifilm Europe appoints Ralf Petersen as Workflow & Solution Consultant, Packag...
27/10/2022
Fujifilm's New INSTAX SQUARE Link Smartphone Printer brings Augmented Realit...
27/10/2022
Fujifilm announces availability of its Revoria range in Switzerland Fujifilm's Revoria Press PC1120 and E1 series toner presses are now available in Switz...
26/10/2022
Vario Press Ltd adds Fujifilm Acuity Prime to its portfolio The UK print and marketing agency has witnessed an increase in production speeds following their i...
24/10/2022
Floricolor expands business offering and increases revenue with investment in Fu...
21/10/2022
Fujifilm UK opens new strategic headquarters in Bedford New sustainability-focused HQ for Fujifilm UK - graded BREEAM Excellent' - is officially opened w...
20/10/2022
Fujifilm announces joint development with Barber n to bring high quality, single...
07/10/2022
Nineteen products in a wide range of categories win Good Design Award - Fujifilm picks up the largest number of awards for four consecutive years
- Medical ...
06/10/2022
Fujifilm to establish its first Bio-CDMO site in Japan Accelerating business growth of the life sciences field and contributing to the strengthening of domest...
28/09/2022
FUJIFILM Dimatix Supports OEMs with New STARFIRE Printheads for Printing with E...
26/09/2022
FUJIFILM Sonosite announces the European launch of Sonosite LX, the industry lea...
14/09/2022
Fujifilm further invests USD 20 million in next-generation battery company, 24M ...
13/09/2022
Premista Series of zoom lenses for cinema cameras wins Silver in the internation...
12/09/2022
FUJIFILM Diosynth Biotechnologies breaks ground on a USD 1.6 billion (11 billio...
05/09/2022
Fujifilm unveils expanded pulmonology solutions portfolio with addition of new s...
31/08/2022
VISION 2022: FUJIFILM presents heavy-duty lens series HF-XA-1F At the world leading machine vision show, FUJIFILM showcases its industrial lens lineup with ou...
26/08/2022
Lights, Cameras, Dissertations! Fujifilm present prize for highest mark in Resea...